MedTrace Logo

Treatment of Adults With Growth Hormone Deficiency

NCT00294619 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2012-10-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy and safety profile of a new weekly administered growth hormone preparation compared with placebo in adults with growth hormone deficiency.

Conditions

  • Pituitary Disorders
  • Adult Growth Hormone Deficiency

Interventions

DRUG

growth hormone

subcutaneous injection, once-weekly

Sponsors & Collaborators

  • BioPartners GmbH

    collaborator INDUSTRY

  • LG Life Sciences

    lead INDUSTRY

Principal Investigators

  • HJ Ji, PhD · LG Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00294619 on ClinicalTrials.gov